Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 16165347)

1.

Radiochemotherapy in Anal Cancer: cCR, clinical outcomes and quality of life using two different treatment schedules.

Di Santo S, Trignani M, Neri M, Milano A, Innocenti P, Taraborrelli M, Augurio A, Vinciguerra A, Di Tommaso M, Ursini LA, Di Pilla A, Di Nicola M, Genovesi D.

Rep Pract Oncol Radiother. 2014 Nov 22;20(2):128-34. doi: 10.1016/j.rpor.2014.11.001. eCollection 2015 Mar-Apr.

PMID:
25859401
2.

Development of cerebral metastasis after medical and surgical treatment of anal squamous cell carcinoma.

Austin Gassman A, Fernando E, Holmes CJ, Kapur U, Eberhardt JM.

Case Rep Oncol Med. 2012;2012:912178. doi: 10.1155/2012/912178. Epub 2012 Oct 9.

3.

Long term outcome after combined modality treatment for anal cancer.

Oblak I, Petric P, Anderluh F, Velenik V, Fras PA.

Radiol Oncol. 2012 Jun;46(2):145-52. doi: 10.2478/v10019-012-0022-2. Epub 2012 Apr 11.

4.

Anal dysplasia screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(4):1-43. Epub 2007 Jun 1.

5.

Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.

Lampejo T, Kavanagh D, Clark J, Goldin R, Osborn M, Ziprin P, Cleator S.

Br J Cancer. 2010 Dec 7;103(12):1858-69. doi: 10.1038/sj.bjc.6605984. Epub 2010 Nov 9. Review.

6.

Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations.

Mathews C, Caperna J, Cachay ER, Cosman B.

Open AIDS J. 2007;1:11-20. doi: 10.2174/1874613600701010011. Epub 2007 Nov 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk